IIf someone told you there’s nothing to be done about your symptoms, that isn’t true. And if you were handed one option and left to figure out the rest, you’re seeing a small part of a much bigger picture.
Treatment for menopause symptoms falls into four groups: hormone therapy that works through your whole body, low-dose estrogen used in the vagina, prescription medicines that aren’t hormones, and behavioral approaches that have been tested in trials.
Here’s the most useful thing to know before you go any further. The right choice depends on which symptom is bothering you, not on how far along you are. Hot flashes, vaginal dryness, and bone loss each respond to different things, and something that works well for one often does nothing at all for another. So the question worth bringing to your provider isn’t “what treats menopause?” It’s “what treats this?”
Hormone Therapy (Whole Body)
This is the most effective treatment we have for hot flashes and night sweats. It also slows the bone loss that speeds up after your last period.
If you still have your uterus, you take estrogen along with a progestogen, which protects the lining of your uterus. If you’ve had a hysterectomy, you take estrogen alone.
Estrogen comes as a patch or gel you use on your skin, or as a pill you swallow. Large observational studies link the patch and gel to a lower risk of blood clots in the veins than the pill. Both relieve symptoms well, so this is a genuine choice rather than a right and wrong answer.
Medical groups describe the balance of benefits and risks as generally favorable for healthy women who start before age sixty, or within ten years of their last period. Starting later shifts that balance, which is why timing comes up so often in these conversations.
It isn’t for everyone. Hormone therapy is generally not used if you have or have had breast cancer or another cancer that feeds on estrogen, vaginal bleeding that hasn’t been explained, a blood clot now or in the past, or active liver disease. Other health conditions don’t rule it out, but they do call for a specialist’s input rather than an automatic no.
A 2026 Update to the Warning Label
In November 2025, the FDA announced it would remove statements about cardiovascular disease, breast cancer, and probable dementia from the boxed warning on menopausal hormone therapy products. In February 2026, it approved that change for the first six products, with more following as manufacturers submit them.
Two things are worth understanding here. First, no new study prompted this. The underlying research didn’t change, only the labeling did, and risk information is still described elsewhere on the label. Second, the warning about uterine cancer remains on systemic estrogen taken without a progestogen.
Low-Dose Vaginal Estrogen (Local)
Two newer medicines were developed specifically for hot flashes. Both work on a brain pathway involved in temperature control rather than on your hormones.
- Fezolinetant (Veozah), approved in 2023, carries a boxed warning for rare but serious liver injury. It requires a liver blood test before you start and at points during treatment.
- Elinzanetant (Lynkuet), approved in October 2025, doesn’t carry a boxed warning, but its label still calls for a liver blood test before starting and again at three months. Daytime drowsiness is among its warnings, and it’s taken at bedtime.
Certain antidepressants in the SSRI and SNRI families also reduce hot flashes. A low dose of paroxetine is FDA-approved for this purpose; others are used off-label, meaning the medicine is approved for something else but prescribed here based on evidence. One caution matters a great deal for some women: paroxetine can make tamoxifen work less effectively.
Gabapentin and oxybutynin have supporting evidence too, each with its own side effects to weigh. Stellate ganglion block, an injection near a group of nerves in the neck, appears in current guidance as well, though it’s used far less often.
Approaches With Evidence Behind Them
Cognitive behavioral therapy (CBT) and clinical hypnosis are both recommended for hot flashes and night sweats in The Menopause Society’s 2023 statement on non-hormone treatments.
These work a little differently than you might expect. They don’t stop the hot flash so much as reduce how much it disrupts you. That means the distress, the broken sleep, and the effect on your day.
CBT for insomnia is separately considered a first-choice treatment for long-term sleep problems. That matters, because sleep is often the symptom that finally pushes women to seek help. Weight loss is also among the approaches that statement recommends for hot flashes.
What Isn’t Recommended for Hot Flashes
The same 2023 statement lists approaches it doesn’t recommend specifically for hot flashes and night sweats: supplements and herbal products, soy products, acupuncture, paced breathing, cooling techniques, trigger avoidance, exercise, yoga, mindfulness, relaxation, diet changes, cannabinoids, clonidine, and pregabalin.
Please read that list carefully, because it’s easy to misread.
It’s about hot flashes only. Exercise and a good eating pattern have clear, well-documented value for your heart, your bones, your muscle, and your mood. They simply haven’t shown a reliable effect on hot flashes in trials. Appearing on that list says nothing about their other benefits.
Bones and Long-Term Health
Bone loss speeds up in the years around your final period, and it happens quietly. Most women feel nothing at all until a fracture.
Hormone therapy prevents this bone loss. If you don’t use hormone therapy, other approved medicines for bone loss and osteoporosis are available. Standard bone care after menopause also includes enough calcium and vitamin D, weight-bearing activity such as walking, and resistance training such as lifting weights or using bands.
Heart risk factors shift after menopause as well. Cholesterol and blood pressure often rise during this period, which is why they’re usually monitored more closely, along with blood sugar. Ask for those numbers at your next visit rather than waiting to be told.
Compounded “Bioidentical” Hormones
Custom-mixed hormone preparations, often marketed as bioidentical, are not recommended by professional medical groups for menopause symptoms. There are three reasons.
The dose isn’t standardized, so two batches may not be the same. Purity and strength aren’t verified the way they are for FDA-approved products. And saliva hormone testing, often used to set the dose, doesn’t reliably reflect hormone levels in your tissues.
Here’s the part that surprises people: FDA-approved hormone therapy already includes products chemically identical to the estradiol and progesterone your own body makes. You don’t have to use a compounded product to get that.
Hormone therapy is the most effective treatment available. Whether it suits you depends on your personal and family health history, so it needs an individual assessment.
Fezolinetant and elinzanetant, which act on a brain pathway involved in temperature control, plus certain SSRIs and SNRIs, gabapentin, and oxybutynin.
Yes. Fezolinetant carries a boxed warning for rare but serious liver injury and needs liver blood tests before you start and during treatment. Elinzanetant has no boxed warning, but its label also calls for liver tests before starting and at three months.
Observational studies link estrogen through the skin with a lower risk of blood clots in the veins. Both relieve symptoms well.
Current guidance doesn’t recommend them for hot flashes. Tell your provider what you take, since some supplements interact with prescription medicines.
No. That guidance is about hot flashes specifically. Exercise keeps its well-established value for your heart, bones, muscle, weight, and mood.
Name your top two symptoms and how much they affect your daily life, and say what you’ve already tried. Share your personal and family history, especially breast cancer, blood clots, stroke, and liver disease. Then ask which of the four groups makes sense given that history.
Bottom Line
There are more options than most women are shown. Match the treatment to the symptom rather than to the stage, and expect that you may need more than one thing at once. A whole-body treatment for hot flashes plus a local one for vaginal symptoms is a common combination, not a sign that something has gone wrong.
If you were offered a single option and nothing else, it’s entirely reasonable to ask about the rest. If your provider isn’t comfortable with menopause care, asking for a referral to someone who is isn’t rude. It’s the right move.
